Placebo(SAD)

DRUG2 trials

Sponsors

Nanjing RegeneCore Biotech Co., Ltd., Sunshine Lake Pharma Co., Ltd.

Conditions

HBV InfectionHealthy Volunteers

Phase 1

A Phase I Study of RC1416 Injection

CompletedNCT06067490

Nanjing RegeneCore Biotech Co., Ltd.Healthy Volunteers

Start: 2023-06-29End: 2024-05-14Updated: 2024-12-02

A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B

RecruitingNCT07771140

Sunshine Lake Pharma Co., Ltd.HBV Infection

Start: 2025-12-02End: 2027-04-11Target: 78Updated: 2026-08-18